(Q34699129)

English

Evaluation of the incidence and risk of hypoglycemic coma associated with selection of basal insulin in the treatment of diabetes: a Finnish register linkage study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 August 2017

Evaluation of the incidence and risk of hypoglycemic coma associated with selection of basal insulin in the treatment of diabetes: a Finnish register linkage study (English)

1 reference

Europe PubMed Central

4 August 2017

0 references

1 reference

based on heuristic

inferred from title

hypoglycemic coma

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

4 August 2017

object named as

Fabian Hoti

2

0 references

author name string

Panu Erästö

3

1 reference

Europe PubMed Central

4 August 2017

Tero Saukkonen

4

1 reference

Europe PubMed Central

4 August 2017

Sari Mäkimattila

5

1 reference

Europe PubMed Central

4 August 2017

Pasi Korhonen

6

1 reference

Europe PubMed Central

4 August 2017

publication date

21 October 2013

1 reference

Europe PubMed Central

4 August 2017

Pharmacoepidemiology and Drug Safety

1 reference

Europe PubMed Central

4 August 2017

22

1 reference

Europe PubMed Central

4 August 2017

12

1 reference

Europe PubMed Central

4 August 2017

1326-1335

1 reference

Europe PubMed Central

4 August 2017

Framing the decision to contract out elderly care and primary health care services - perspectives of local level politicians and civil servants in Finland

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265848

7 July 2018

Emergency hospitalizations for adverse drug events in older Americans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265848

7 July 2018

Severe hypoglycaemia in drug-treated diabetic patients needs attention: a population-based study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265848

7 July 2018

Long-acting insulin analogs: a review of "real-world" effectiveness in patients with type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265848

7 July 2018

Observational, open-label study of type 1 and type 2 diabetes patients switching from human insulin to insulin analogue basal-bolus regimens: insights from the PREDICTIVE study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265848

7 July 2018

Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265848

7 July 2018

Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265848

7 July 2018

Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265848

7 July 2018

Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265848

7 July 2018

Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes: a randomized clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265848

7 July 2018

Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265848

7 July 2018

Metabolic alterations in middle-aged and elderly lean patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FPDS.3534

21 January 2018

Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FPDS.3534

21 January 2018

The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2FPDS.3534

21 January 2018

The validity of death certificates: routine validation of death certification and its effects on mortality statistics.

1 reference

https://api.crossref.org/works/10.1002%2FPDS.3534

21 January 2018

Evaluating Medication Effects Outside of Clinical Trials: New-User Designs

1 reference

https://api.crossref.org/works/10.1002%2FPDS.3534

21 January 2018

Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1002%2FPDS.3534

21 January 2018

An observational non-interventional study of people with diabetes beginning or changed to insulin analogue therapy in non-Western countries: the A1chieve study

1 reference

https://api.crossref.org/works/10.1002%2FPDS.3534

21 January 2018

Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FPDS.3534

21 January 2018

Fasting plasma glucose variability as a marker of nocturnal hypoglycemia in diabetes: evidence from the PREDICTIVE study

1 reference

https://api.crossref.org/works/10.1002%2FPDS.3534

21 January 2018

Severe hypoglycemia and risks of vascular events and death

1 reference

https://api.crossref.org/works/10.1002%2FPDS.3534

21 January 2018

Severe hypoglycaemia and late-life cognitive ability in older people with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study.

1 reference

https://api.crossref.org/works/10.1002%2FPDS.3534

21 January 2018

Cost of hypoglycemia in patients with Type 2 diabetes in Sweden

1 reference

https://api.crossref.org/works/10.1002%2FPDS.3534

21 January 2018

Costs of managing severe hypoglycaemia in three European countries

1 reference

https://api.crossref.org/works/10.1002%2FPDS.3534

21 January 2018

Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study

1 reference

https://api.crossref.org/works/10.1002%2FPDS.3534

21 January 2018

Neurocognitive functioning in children with type-1 diabetes with and without episodes of severe hypoglycaemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265848

26 October 2018

Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration

1 reference

https://api.crossref.org/works/10.1002%2FPDS.3534

21 January 2018

Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FPDS.3534

21 January 2018

Transferring to insulin detemir from NPH insulin or insulin glargine in type 2 diabetes patients on basal-only therapy with oral antidiabetic drugs improves glycaemic control and reduces weight gain and risk of hypoglycaemia: 14-week follow-up data

1 reference

https://pubmed.ncbi.nlm.nih.gov/24150837

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naive People With Type 2 Diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/24150837

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypoglycaemia: a therapeutic concern in type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/24150837

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/PDS.3534

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34699129&oldid=1601886088"